Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin
Open Access
- 1 March 2007
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 117 (3), 683-692
- https://doi.org/10.1172/jci28523
Abstract
Aminoglycosides can readthrough premature termination codons (PTCs), permitting translation of full-length proteins. Previously we have found variable efficiency of readthrough in response to the aminoglycoside gentamicin among cystic fibrosis (CF) patients, all carrying the W1282X nonsense mutation. Here we demonstrate that there are patients in whom the level of CF transmembrane conductance regulator (CFTR) nonsense transcripts is markedly reduced, while in others it is significantly higher. Response to gentamicin was found only in patients with the higher level. We further investigated the possibility that the nonsense-mediated mRNA decay (NMD) might vary among cells and hence governs the level of nonsense transcripts available for readthrough. Our results demonstrate differences in NMD efficiency of CFTR transcripts carrying the W1282X mutation among different epithelial cell lines derived from the same tissue. Variability was also found for 5 physiologic NMD substrates, RPL3, SC35 1.6 kb, SC35 1.7 kb, ASNS, and CARS. Importantly, our results demonstrate the existence of cells in which NMD of all transcripts was efficient and others in which the NMD was less efficient. Downregulation of NMD in cells carrying the W1282X mutation increased the level of CFTR nonsense transcripts and enhanced the CFTR chloride channel activity in response to gentamicin. Together our results suggest that the efficiency of NMD might vary and hence have an important role in governing the response to treatments aiming to promote readthrough of PTCs in many genetic diseases.Keywords
This publication has 68 references indexed in Scilit:
- α-l-Iduronidase Premature Stop Codons and Potential Read-Through in Mucopolysaccharidosis Type I PatientsJournal of Molecular Biology, 2004
- Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamicsNature Reviews Molecular Cell Biology, 2004
- Negamycin Restores Dystrophin Expression in Skeletal and Cardiac Muscles of mdx MiceThe Journal of Biochemistry, 2003
- Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humansProceedings of the National Academy of Sciences of the United States of America, 2002
- Separable Roles for rent1/hUpf1 in Altered Splicing and Decay of Nonsense TranscriptsScience, 2002
- An mRNA Surveillance Mechanism That Eliminates Transcripts Lacking Termination CodonsScience, 2002
- Long mutant dystrophins and variable phenotypes: evasion of nonsense-mediated decay?Human Genetics, 2001
- A strategy for disease gene identification through nonsense-mediated mRNA decay inhibitionNature Biotechnology, 2001
- SC35 autoregulates its expression by promoting splicing events that destabilize its mRNAsThe EMBO Journal, 2001
- A Regulatory Mechanism That Detects Premature Nonsense Codons in T-cell Receptor Transcripts in Vivo Is Reversed by Protein Synthesis Inhibitors in VitroJournal of Biological Chemistry, 1995